Regeneron president on new data revealing COVID-19 antibody cocktail significantly reduces infection risk

George Yancopoulos, the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals argues the company's antibody cocktail 'is a way to protect' the most vulnerable, including the immunocompromised.